Howard Horn
Chief Financial Officer · 8 filings · Latest: Aug 3, 2026
Ultragenyx Pharmaceutical Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RARE | Howard Horn | Chief Financial Officer | Aug 3, 2026 | Sale | $24.92 | 4,696 | $117.0K | 96,295 | |
RARE | HOWARD HORN | — | Aug 3, 2026 | Proposed Sale | $24.92 | 4,696 | $117.0K | — | |
RARE | Howard Horn | Chief Financial Officer | Jul 1, 2026 | Sale | $33.13 | 4,698 | $155.6K | 100,991 | |
RARE | HOWARD HORN | — | Jul 1, 2026 | Proposed Sale | $33.13 | 4,698 | $155.6K | — | |
RARE | Howard Horn | Chief Financial Officer | Jun 1, 2026 | Sale | $23.77 | 4,653 | $110.6K | 105,689 | |
RARE | HOWARD HORN | — | Jun 1, 2026 | Proposed Sale | $23.77 | 4,653 | $110.6K | — | |
RARE | Howard Horn | Chief Financial Officer | May 1, 2026 | Sale | $24.90 | 4,683 | $116.6K | 110,342 | |
RARE | HOWARD HORN | — | May 1, 2026 | Proposed Sale | $24.90 | 4,683 | $116.6K | — | |
RARE | Howard Horn | Chief Financial Officer | Apr 1, 2026 | Sale | $20.97 | 4,683 | $98.2K | 80,351 | |
RARE | HOWARD HORN | — | Apr 1, 2026 | Proposed Sale | $20.97 | 4,683 | $98.2K | — | |
RARE | Howard Horn | Chief Financial Officer | Mar 3, 2026 | Sale | $22.40 | 1,635 | $36.6K | 85,034 | |
RARE | Howard Horn | Chief Financial Officer | Mar 2, 2026 | Sale | $22.70 | 8,409 | $190.9K | 86,669 | |
RARE | HOWARD HORN | — | Mar 3, 2026 | Proposed Sale | $22.40 | 1,635 | $36.6K | — | |
RARE | HOWARD HORN | — | Mar 2, 2026 | Proposed Sale | $22.54 | 3,119 | $70.3K | — | |
RARE | Howard Horn | Chief Financial Officer | Feb 2, 2026 | Sale | $23.56 | 3,061 | $72.1K | 88,935 | |
RARE | HOWARD HORN | — | Feb 2, 2026 | Proposed Sale | $23.56 | 3,061 | $72.1K | — | |
RARE | HOWARD HORN | — | Jan 2, 2026 | Proposed Sale | $22.84 | 3,150 | $71.9K | — | |
RARE | HOWARD HORN | — | Dec 10, 2025 | Proposed Sale | $36.38 | 3,081 | $112.1K | — |